Hot topics close

Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020

CanFite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today it is implementing an interim analysis of the Phas
Similar news
News Archive
  • Damian Hurley
    Damian Hurley
    Revealed: Liz Hurley's fury after son Damian is cut out of £180million after an epic legal battle over his grandfather's ...
    3 Jul 2021
    6
  • St David
    St David
    Minister for Social Justice strengthens ties with Irish Government ...
    1 Mar 2024
    1
  • Phil Collins
    Phil Collins
    Phil Collins is “much more immobile than he used to be,” says Genesis bandmate in health update
    11 Mar 2023
    7
  • Hennessy
    Hennessy
    Moët Hennessy Travel Retail on “deepening the connection” with Chinese consumers
    10 Feb 2024
    1
This week's most popular news